Ob.Gyn. NewsBlack Women With Breast Cancer Face Clinical InequitiesJuly 26, 2024Breast CancerDiversity in Medicine
Ob.Gyn. NewsGreater Transparency of Oncologists’ Pharma Relationships NeededJuly 22, 2024Practice ManagementPreventive CareBreast CancerDiversity in MedicineGynecologic CancerMixed TopicsBusiness of Medicine
Ob.Gyn. NewsCould an EHR Nudge Reduce Unnecessary Biopsies?July 18, 2024Breast CancerPreventive CareBusiness of MedicinePractice Management
Ob.Gyn. NewsCognitive Decline Minimal After Endocrine + CDK4/6 Inhibition in BCJuly 17, 2024Breast Cancer
Ob.Gyn. NewsEribulin Similar to Taxane When Paired With Dual HER2 Blockade in BCJuly 10, 2024Breast Cancer
Ob.Gyn. NewsPFS Benefits Seen With Palbociclib + Endocrine Therapy in Breast CancerJuly 10, 2024Breast Cancer
Ob.Gyn. NewsNew Canadian BC Guidelines Emphasize Personal ChoiceJuly 10, 2024Breast CancerPreventive Care
Ob.Gyn. NewsShould Cancer Trial Eligibility Become More Inclusive?July 10, 2024Practice ManagementBreast CancerGynecologic CancerOpioid Resource CenterBusiness of MedicineMixed Topics
Ob.Gyn. NewsWeight Loss Drugs Cut Cancer Risk in Diabetes PatientsJuly 8, 2024Preventive CareBreast CancerGynecologic CancerMixed Topics
Ob.Gyn. NewsAdjuvant Avelumab Benefits Seen in High Risk, Triple Negative BCJuly 8, 2024Breast Cancer
Ob.Gyn. NewsClinical Controversy: Standard Dose or Baby TAM for Breast Cancer Prevention?July 5, 2024Breast CancerPreventive Care
